Bacterial isolates from hematology, oncology, and intensive care units: Susceptibility to cefpirome and other beta-lactam antibiotics in a multicenter study in Mexico
Ji. Santos et al., Bacterial isolates from hematology, oncology, and intensive care units: Susceptibility to cefpirome and other beta-lactam antibiotics in a multicenter study in Mexico, CURR THER R, 61(5), 2000, pp. 266-276
Citations number
17
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
Objective: An in vitro multicenter study mas conducted in 15 Mexican hospit
als from September 1995 to May 1996 to provide data on the prevalence of ba
cterial isolates from patients in hematology, oncology, and intensive care
units, as well as data on the sensitivity of these organisms to cefpirome a
nd other antimicrobial drugs commonly used in these units.
Methods: Each participating center collected an average of 100 aerobic bact
erial isolates from significant clinical specimens. Minimum inhibitory conc
entrations to cefpirome and 7 other betalactam antibiotics commonly used em
pirically to treat nosocomial infections in critically ill patients were de
termined by the microdilution method.
Results: The most frequent sources of the isolates were blood (37.1%), bron
choalveolar lavage fluid (16.8%), skin or wounds (15.8%), and urine (14.0%)
. The isolated bacteria mere distributed as follows: gram-negative enteric
bacilli (40.8%), gram-negative nonenteric bacilli (88.8%), and gram-positiv
e cocci (20.4%).
Conclusions: Multiresistant gram-negative enteric and nonenteric bacilli me
re the most important pathogens isolated in hospitalized, critically ill pa
tients; however, gram-positive cocci (both staphylococcus and enterococcus)
accounted for 20.4% of the isolates. Although the activity of cefpirome wa
s similar or superior to that of the other antibiotics tested in this study
, our results clearly stress the need for antimicrobial agents that are eff
ective against infections caused by gram-negative and gram-positive bacteri
a in critically ill patients.